Ad
related to: high risk essential thrombocythemia- About Chronic ITP
Learn More About What It Is
& How It Is Treated.
- Connect With Coordinators
Click To Download Our Forms
Or Get Assistance.
- View Prescribing Info
Click To Find Full Prescribing
Info For This Medication.
- Join For Exclusive Tips
Sign Up For Our Community Tips
Delivered To Your Doorstep & Inbox
- About Chronic ITP
Search results
Results from the WOW.Com Content Network
Essential thrombocythemia is sometimes described as a slowly progressive disorder with long asymptomatic periods punctuated by thrombotic or hemorrhagic events. [15] However, well-documented medical regimens can reduce and control the number of platelets, which reduces the risk of these thrombotic or hemorrhagic events.
However, in essential thrombocythemia where platelet counts are over 750x10 9 /L or 1,000x10 9 /L, especially if there are other risk factors for thrombosis, treatment may be needed. Selective use of aspirin at low doses is thought to be protective.
Anagrelide is used to treat essential thrombocytosis, especially when the current treatment of the patient is insufficient. [4] Essential thrombocytosis patients who are suitable for anagrelide often meet one or more of the following factors: [5] [6] age over 60 years; platelet count over 1000×10 9 /L; a history of thrombosis
Pregnancy is associated with an increased risk of thrombosis of 2- to 7-fold. [25] This probably results from a physiological hypercoagulability in pregnancy that protects against postpartum hemorrhage. [26] This hypercoagulability in turn is likely related to the high levels of estradiol and progesterone that occur during pregnancy. [27]
Hydroxycarbamide, also known as hydroxyurea, is an antimetabolite medication used in sickle-cell disease, essential thrombocythemia, chronic myelogenous leukemia, polycythemia vera, and cervical cancer. [4] [5] In sickle-cell disease it increases fetal hemoglobin and decreases the number of attacks. [4] It is taken by mouth. [4]
Thrombocythemia (overproduction of platelets in bone marrow) Henoch-Schonlein purpura (small blood vessel inflammation) Priapism commonly occurs in men with sickle cell disease, and the risk ...
But women at higher risk may need to start younger. High-risk women and those with dense breasts may need supplemental testing in addition to mammography. Women who have dense breasts and/or other ...
For intermediate risk patients, symptom driven therapy for anaemia or constitutional symptoms. [citation needed] For high risk patients with a history of thrombosis, oral anticoagulants and cytoreductive drugs such as hydroxycarbamide are recommended, and the patient should be treated as in primary myelofibrosis. [1] [3]
Ad
related to: high risk essential thrombocythemia